Abstract
The encapsulation of antitumor drugs in nanosized systems with pH-sensitive behavior is a promising approach that may enhance the success of chemotherapy in many cancers. The nanocarrier dependence on pH might trigger an efficient delivery of the encapsulated drug both in the acidic extracellular environment of tumors and, especially, in the intracellular compartments through disruption of endosomal membrane. In this context, here we reported the preparation of chitosan-based nanoparticles encapsulating methotrexate as a model drug (MTX-CS-NPs), which comprises the incorporation of an amino acid-based amphiphile with pH-responsive properties (77KS) on the ionotropic complexation process. The presence of 77KS clearly gives a pH-sensitive behavior to NPs, which allowed accelerated release of MTX with decreasing pH as well as pH-dependent membrane-lytic activity. This latter performance demonstrates the potential of these NPs to facilitate cytosolic delivery of endocytosed materials. Outstandingly, the cytotoxicity of MTX-loaded CS-NPs was higher than free drug to MCF-7 tumor cells and, to a lesser extent, to HeLa cells. Based on the overall results, MTX-CS-NPs modified with the pH-sensitive surfactant 77KS could be potentially useful as a carrier system for intracellular drug delivery and, thus, a promising targeting anticancer chemotherapeutic agent.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agnihotri SA, Mallikarjuna NN, Aminabhavi TM (2004) Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 100:5–28. doi:10.1016/j.jconrel.2004.08.010
Akagi T, Kim H, Akashi M (2010) pH-dependent disruption of erythrocyte membrane by amphiphilic poly(amino acid) nanoparticles. J Biomater Sci 21:315–328. doi:10.1163/156856209X418519
Banerjee D, Mayer-Kuckuk P, Capiaux G, Budak-Alpdogan T, Gorlick R, Bertino JR (2002) Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim Biophys Acta 1587:164–173. doi:10.1016/S0925-4439(02)00079-0
Bao H, Li L, Zhang H (2008) Influence of cetyltrimethylammonium bromide on physicochemical properties and microstructures of chitosan-TPP nanoparticles in aqueous solutions. J Coll Interface Sci 328:270–277. doi:10.1016/j.jcis.2008.09.003
Berger J, Reist M, Mayer JM, Felt O, Peppas NA, Gurny R (2004) Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm 57:19–34. doi:10.1016/S0939-6411(03)00161-9
Borenfreund E, Puerner JA (1985) Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 24:119–124
Calvo P, Remuñan-López C, Vila-Jato JL, Alonso MJ (1997) Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res 14:1431–1436. doi:10.1023/A:1012128907225
Chen YH, Tsai CY, Huang PY, Chang MY, Cheng PC, Chou CH, Chen DH, Wang CR, Shiau AL, Wu CL (2007) Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol Pharmac 4:713–722. doi:10.1021/mp060132k
Chen R, Khormaee S, Eccleston ME, Slater NKH (2009) The role of hydrophobic amino acid grafts in the enhancement of membrane-disruptive activity of pH-responsive pseudo-peptides. Biomaterials 30:1954–1961. doi:10.1016/j.biomaterials.2008.12.036
Chen J, Huang L, Lai H, Lu C, Fang M, Zhang Q, Luo X (2014) Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity. Mol Pharm 11:2213–2223. doi:10.1021/mp400269z
Das M, Sahoo SK (2011) Epithelial cell adhesion molecule targeted nutlin-3a loaded immunonanoparticles for cancer therapy. Acta Biomater 7:355–369. doi:10.1016/j.actbio.2010.08.010
Deng X, Cao M, Zhang J, Hu K, Yin Z, Zhou Z, Xiao X, Yang Y, Sheng W, Wu Y, Zeng Y (2014) Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer. Biomaterials 35:4333–4344. doi:10.1016/j.biomaterials.2014.02.006
Dong X, Mumper RJ (2010) Nanomedicinal strategies to treat multidrug-resistant tumors: current progress. Nanomedicine 5:597–615. doi:10.2217/nnm.10.35
Elbakry A, Wurster EC, Zaky A, Liebl R, Schindler E, Bauer-Kreisel P, Blunk T, Rachel R, Goepferich A, Breunig M (2012) Layer-by-layer coated gold nanoparticles: size-dependent delivery of DNA into cells. Small 8:3847–3856. doi:10.1002/smll.201201112
ETPN (2015) The European Technology Platform on Nanomedicine. Available at http://www.etp-nanomedicine.eu/public. Accessed 12 Jan 2015
Fan W, Yan W, Xu Z, Ni H (2012) Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surf B Biointerfaces 90:21–27. doi:10.1016/j.colsurfb.2011.09.042
Gan Q, Wang T (2007) Chitosan nanoparticle as protein delivery carrier—systematic examination of fabrication conditions for efficient loading and release. Colloids Surf B Biointerfaces 59:24–34. doi:10.1016/j.colsurfb.2007.04.009
Gan Q, Wang T, Cochrane C, McCarron P (2005) Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces 44:65–73. doi:10.1016/j.colsurfb.2005.06.001
Gonen N, Assaraf YG (2012) Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance. Drug Resist Updat 15:183–210. doi:10.1016/j.drup.2012.07.002
Hu Y, Litwin T, Nagaraja AR, Kwong B, Katz J, Watson N, Irvine DJ (2007) Cytosolic delivery of membrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. Nano Lett 7:3056–3064. doi:10.1021/nl071542i
Huang K, Ma H, Liu J, Huo S, Kumar A, Wei T, Zhang X, Jin S, Gan Y, Wang PC, He S, Zhang X, Liang X-J (2012) Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano 6:4483–4493. doi:10.1021/nn301282m
Jia M, Li Y, Yang X, Huang Y, Wu H, Huang Y, Lin J, Li Y, Hou Z, Zhang Q (2014) Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect. ACS Appl Mater Interfaces 6:11413–11423. doi:10.1021/am501932s
Kuznetsova NR, Vodovozova EL (2014) Differential binding of plasma proteins by liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the bilayer. Biochemistry 79:797–804. doi:10.1134/S0006297914080070
Kuznetsova NR, Sevrin C, Lespineux D, Bovin NV, Vodovozova EL, Meszaros T, Szebeni J, Grandfils C (2012) Hemocompatibility of liposomes loaded with lipophilic prodrugs of methotrexate and melphalan in the lipid bilayer. J Control Release 160:394–400. doi:10.1016/j.jconrel.2011.12.010
Lee ES, Gao Z, Bae YH (2008) Recent progress in tumor pH targeting nanotechnology. J Control Release 132:164–170. doi:10.1016/j.jconrel.2008.05.003
Lee Y-J, Johnson G, Pellois J-P (2010) Modeling of the endosomolytic activity of HA2-TAT peptides with red blood cells and ghosts. Biochemistry 49:7854–7866. doi:10.1021/bi1008408
Li Y, Wang J, Wientjes MG, Au JL (2012) Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor. Adv Drug Deliv Rev 6:29–39. doi:10.1016/j.addr.2011.04.006
Luo F, Li Y, Jia M, Cui F, Wu H, Yu F, Lin J, Yang X, Hou Z, Zhang Q (2014) Validation of a Janus role of methotrexate-based PEGylated chitosan nanoparticles in vitro. Nanoscale Res Lett 9:363. doi:10.1186/1556-276X-9-363
Mao S, Sun W, Kissel T (2010) Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev 62:12–27. doi:10.1016/j.addr.2009.08.004
Mosmann T (1983) Rapid colorimetric assay to cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63. doi:10.1016/0022-1759(83)90303-4
Na K, Lee ES, Bae YH (2003) Adriamycin loaded pullulan acetate/sulfonamide conjugate nanoparticles responding to tumor pH: pH-dependent cell interaction, internalization and cytotoxicity in vitro. J Control Release 87:3–13. doi:10.1016/S0168-3659(02)00345-0
Nogueira DR, Mitjans M, Infante MR, Vinardell MP (2011a) The role of counterions in the membrane-disruptive properties of pH-sensitive lysine-based surfactants. Acta Biomater 7:2846–2856. doi:10.1016/j.actbio.2011.03.017
Nogueira DR, Mitjans M, Infante MR, Vinardell MP (2011b) Comparative sensitivity of tumor and non-tumor cell lines as a reliable approach for in vitro cytotoxicity screening of lysine-based surfactants with potential pharmaceutical applications. Int J Pharm 420:51–58. doi:10.1016/j.ijpharm.2011.08.020
Nogueira DR, Tavano L, Mitjans M, Pérez L, Infante MR, Vinardell MP (2013) In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles. Biomaterials 34:2758–2772. doi:10.1016/j.biomaterials.2013.01.005
Nogueira DR, Macedo LB, Scheeren LE, Mitjans M, Infante MR, Rolim CMB, Vinardell MP (2014a) Determination of Methotrexate in pH-Sensitive Chitosan Nanoparticles by Validated RP-LC and UV Spectrophotometric Methods. J Appl Biopharm Pharmacokinet. (In press)
Nogueira DR, Mitjans M, Vinardell MP (2014b) Nanotechnology approaches to target rndosomal pH: a promising strategy for an efficient intracellular drug, gene and protein delivery. Drug Deliv Lett 4:2–11. doi:10.2174/221030310401140410115042
Plank C, Oberhauser B, Mechtler K, Koch C, Wagner E (1994) The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem 269:12918–12924
Plank C, Zauner W, Wagner E (1998) Application of membrane-active peptides for drug and gene delivery across cellular membranes. Adv Drug Deliv Rev 34:21–35. doi:10.1016/S0169-409X(98)00005-2
Rubino FM (2001) Separation methods for methotrexate, its structural analogues and metabolites. J Chromatogr B 764:217–254. doi:10.1016/S0378-4347(01)00402-9
Sánchez L, Mitjans M, Infante MR, Vinardell MP (2006) Potential irritation of lysine derivative surfactants by hemolysis and HaCaT cell viability. Toxicol Lett 161:53–60. doi:10.1016/j.toxlet.2005.07.015
Sánchez L, Mitjans M, Infante MR, García MT, Manresa MA, Vinardell MP (2007) The biological properties of lysine-derived surfactants. Amino Acids 32:133–136. doi:10.1007/s00726-006-0318-x
Stayton PS, Hoffman AS, Murthy N, Lackey C, Cheung C, Tan P, Klumb LA, Chilkoti A, Wilbur FS, Press OW (2000) Molecular engineering of proteins and polymers for targeting and intracellular delivery of therapeutics. J Control Release 65:203–220. doi:10.1016/S0168-3659(99)00236-9
Thomas TP, Huang BH, Choi SK, Silpe JE, Kotlyar A, Desai AM, Zong H, Gam J, Joice M, Baker JR (2012) Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic. Mol Pharmac 9:2669–2676. doi:10.1021/mp3002232
Trapani A, Denora N, Iacobellis G, Sitterberg J, Bakowsky U, Kissel T (2011) Methotrexate-loaded chitosan and glycolchitosan-based nanoparticles: a promising strategy for the administration of the anticancer drug to brain tumors. AAPS Pharm Sci Tech 12:1302–1311. doi:10.1208/s12249-011-9695-x
Vives MA, Infante MR, Gracia E, Selve C, Maugras M, Vinardell MP (1999) Erythrocyte hemolysis and shape changes induce by new lysine-derivate surfactants. Chem Biol Interact 118:1–18. doi:10.1016/S0009-2797(98)00111-2
Wang X-L, Ramusovis S, Nguyen T, Lu Z-R (2007) Novel polymerizable surfactants with pH-sensitive amphiphilicity and cell membrane disruption for efficient siRNA delivery. Bioconj Chem 18:2169–2177. doi:10.1021/bc700285q
Wu P, He X, Wang K, Tan W, He C, Zheng M (2009) A novel methotrexate delivery system based on chitosan-methotrexate covalently conjugated nanoparticles. J Biomed Nanotechnol 5:557–564. doi:10.1166/jbn.2009.1073
Zhao R, Goldman ID (2003) Resistance to antifolates. Oncogene 22:7431–7457. doi:10.1038/sj.onc.1206946
Acknowledgments
This research was supported by Projects 483,264/2012-1 of the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq - Brazil) and MAT2012-38047-C02-01 of the Ministerio de Economía y Competitividad (Spain). Daniele R. Nogueira holds a Postdoctoral fellowship from PNPD-CAPES (Brazil).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors state that they have no conflict of interest.
Additional information
Handling Editor: G.J. Peters.
Rights and permissions
About this article
Cite this article
Nogueira, D.R., Scheeren, L.E., Macedo, L.B. et al. Inclusion of a pH-responsive amino acid-based amphiphile in methotrexate-loaded chitosan nanoparticles as a delivery strategy in cancer therapy. Amino Acids 48, 157–168 (2016). https://doi.org/10.1007/s00726-015-2075-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-015-2075-1